Antiretroviral Rx: Adverse Effects |
|
|
Question | Discussion | References | CME Credit Case 3: Indinavir-Associated NephrotoxicityAuthor: Timothy H. Dellit, MD Case last updated: September 6, 2006 A 30-year-old HIV-infected woman with a CD4 count of 220 cells/mm3 and an HIV-1 RNA level of 80,000 copies/ml is started on zidovudine plus lamivudine (Combivir), and indinavir (Crixivan) plus ritonavir (Norvir). She tolerates this regimen well and after eight weeks of therapy has an undetectable HIV RNA (less than 50 copies/ml) and a CD4 count of 275 cells/mm3. One month later, while on vacation, she develops burning with urination. A local physician diagnoses her with a urinary tract infection and treats her with a 3-day course of trimethoprim-sulfamethoxazole (Bactrim, Septra), without obtaining a urinalysis. Her symptoms do not improve and upon returning from her trip she comes into the office with the additional complaint of right flank pain. Further discussion with the patient reveals that she was unable to maintain her usual fluid intake during her recent travels. A urinalysis reveals starburst crystals, and an abdominal CT scan without contrast is obtained to evaluate possible nephrolithiasis. The CT scan reveals mild right hydronephrosis without evidence of stones. Which of the following statements is most accurate? |
|
Copyright © 2004-2008 University of Washington |
|